» Articles » PMID: 25620782

An Algorithm to Diagnose Influenza Infection: Evaluating the Clinical Importance and Impact on Hospital Costs of Screening with Rapid Antigen Detection Tests

Overview
Publisher Springer
Date 2015 Jan 27
PMID 25620782
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Rapid antigen detection tests (RADTs) are immunoassays that produce results in 15 min or less, have low sensitivity (50 %), but high specificity (95 %). We studied the clinical impact and laboratory savings of a diagnostic algorithm for influenza infection using RADTs as a first-step technique during the influenza season. From January 15th to March 31st 2014, we performed a diagnostic algorithm for influenza infection consisting of an RADT for all respiratory samples received in the laboratory. We studied all the patients with positive results for influenza infection, dividing them into two groups: Group A with a negative RADT but positive reference tests [reverse transcription polymerase chain reaction (RT-PCR) and/or culture] and Group B with an initial positive RADT. During the study period, we had a total of 1,156 patients with suspicion of influenza infection. Of them, 217 (19 %) had a positive result for influenza: 132 (11 %) had an initial negative RADT (Group A) and 85 (7 %) had a positive RADT (Group B). When comparing patients in Group A and Group B, we found significant differences, as follows: prescribed oseltamivir (67 % vs. 82 %; p = 0.02), initiation of oseltamivir before 24 h (89 % vs. 97 %; p = 0.03), antibiotics prescribed (89 % vs. 67 %; p = <0.01), intensive care unit (ICU) admissions after diagnosis (23 % vs. 14 %; p = 0.05), and need for supplementary oxygen (61 % vs. 47 %; p = 0.01). An influenza algorithm including RADTs as the first step improves the time of administration of proper antiviral therapy, reduces the use of antibiotics and ICU admissions, and decreases hospital costs.

Citing Articles

Comparing the cobas Influenza A/B Nucleic acid test for use on the cobas Liat System (Liat) with rapid antigen tests for clinical management of Japanese patients at the point of care.

Mikamo H, Koizumi Y, Yamagishi Y, Asai N, Miyazono Y, Shinbo T PLoS One. 2022; 17(10):e0276099.

PMID: 36301841 PMC: 9612487. DOI: 10.1371/journal.pone.0276099.


Use of Saliva Swab for Detection of Influenza Virus in Patients Admitted to an Emergency Department.

Galar A, Catalan P, Vesperinas L, Miguens I, Munoz I, Garcia-Espona A Microbiol Spectr. 2021; 9(1):e0033621.

PMID: 34431684 PMC: 8552598. DOI: 10.1128/Spectrum.00336-21.


Evaluation of Lateral-Flow Assay for Rapid Detection of Influenza Virus.

Han M, Xie T, Li J, Chen H, Yang X, Guo X Biomed Res Int. 2020; 2020:3969868.

PMID: 32964030 PMC: 7495160. DOI: 10.1155/2020/3969868.


Principles and Practice of Antibiotic Stewardship in the ICU.

Pickens C, Wunderink R Chest. 2019; 156(1):163-171.

PMID: 30689983 PMC: 7118241. DOI: 10.1016/j.chest.2019.01.013.


Detection Methods of Human and Animal Influenza Virus-Current Trends.

Dziabowska K, Czaczyk E, Nidzworski D Biosensors (Basel). 2018; 8(4).

PMID: 30340339 PMC: 6315519. DOI: 10.3390/bios8040094.


References
1.
Subbarao E, Griffis J, Waner J . Detection of multiple viral agents in nasopharyngeal specimens yielding respiratory syncytial virus (RSV). An assessment of diagnostic strategy and clinical significance. Diagn Microbiol Infect Dis. 1989; 12(4):327-32. DOI: 10.1016/0732-8893(89)90098-9. View

2.
Chan K, To K, Chan J, Li C, Chen H, Yuen K . Analytical sensitivity of seven point-of-care influenza virus detection tests and two molecular tests for detection of avian origin H7N9 and swine origin H3N2 variant influenza A viruses. J Clin Microbiol. 2013; 51(9):3160-1. PMC: 3754666. DOI: 10.1128/JCM.01222-13. View

3.
Sakai-Tagawa Y, Ozawa M, Tamura D, Le M, Nidom C, Sugaya N . Sensitivity of influenza rapid diagnostic tests to H5N1 and 2009 pandemic H1N1 viruses. J Clin Microbiol. 2010; 48(8):2872-7. PMC: 2916590. DOI: 10.1128/JCM.00439-10. View

4.
Bell J, Bonner A, Cohen D, Birkhahn R, Yogev R, Triner W . Multicenter clinical evaluation of the novel Alere™ i Influenza A&B isothermal nucleic acid amplification test. J Clin Virol. 2014; 61(1):81-6. DOI: 10.1016/j.jcv.2014.06.001. View

5.
You J, Chan E, Leung M, Ip M, Lee N . A cost-effectiveness analysis of "test" versus "treat" patients hospitalized with suspected influenza in Hong Kong. PLoS One. 2012; 7(3):e33123. PMC: 3315544. DOI: 10.1371/journal.pone.0033123. View